Sonazoid Enhanced Liver Cancer Trial for Early Detection

  • STATUS
    Recruiting
  • participants needed
    760
  • sponsor
    Japan Liver Oncology Group
Send
Updated on 7 November 2020
See if I qualify
liver cancer
cancer
hypertension
hepatitis
cirrhosis

Summary

The aim of this study is to prove usefulness of contrast-enhanced ultrasound (CE-US) using Sonazoid (TM) in the early detection of HCC as compared with conventional B-mode ultrasound (B-mode US) for hepatitis virus related cirrhosis, who are defined as super high-risk patients for hepatocarcinogenesis,Furthermore, to analyze whether early detection of HCC by CE-US has a survival benefit than that by B-mode US.

Details
Condition Cirrhosis, Hepatitis B, Hepatitis C, Hepatitis C virus, HEPATOCELLULAR CARCINOMA
Treatment CE-US (Sonazoid™), B-mode US
Clinical Study IdentifierNCT00822991
SponsorJapan Liver Oncology Group
Last Modified on7 November 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 20 yrs?
Gender: Male or Female
Do you have any of these conditions: Cirrhosis or HEPATOCELLULAR CARCINOMA or Hepatitis B or Hepatitis C virus or Hepatitis C?
Age over 20
HBV or HCV related liver cirrhosis
No history of HCC
Diagnosed as liver cirrhosis histologically or clinically Histologically confirmed by liver biopsy Confirmed by formula of diagnosing cirrhosis Radiological finding Finding of portal hypertension Platelet<130,000
Inpatient or outpatient
Patients who signed a written informed consent form

Exclusion Criteria

History of hypersensitivity to egg yolk
Pregnant or lactating women and women who may be pregnant
Severe liver dysfunction(AST, ALT,or BIL level >10ULN
Associated with HCC
Patients receiving interferon
Age under 20
Judged by investigator not to be appropriate for inclusion in this study
Clear my responses
Read more

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

liver cancer
cancer
hypertension
hepatitis
cirrhosis

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note